BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 27547870)

  • 1. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
    Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
    Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6: An Important Mediator of Allograft Injury.
    Jordan SC; Ammerman N; Choi J; Kumar S; Huang E; Toyoda M; Kim I; Wu G; Vo A
    Transplantation; 2020 Dec; 104(12):2497-2506. PubMed ID: 32235253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model.
    Ma M; Sun Q; Li X; Deng G; Zhang Y; Yang Z; Han F; Huang Z; Fang Y; Liao T; Sun Q
    Front Immunol; 2021; 12():778359. PubMed ID: 34777394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.
    Zhou W; Zhou X; Gaowa S; Meng Q; Zhan Z; Liu J; Li J; Fan H; Liu Z
    Transplantation; 2015 Jul; 99(7):1356-64. PubMed ID: 25856405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab in transplantation.
    Mosharmovahed B; Fatahi Y; Mohebbi B; Ghorbanian SA; Assadiasl S
    Eur J Clin Pharmacol; 2020 Jun; 76(6):765-773. PubMed ID: 32266480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation.
    Liang Y; Christopher K; Finn PW; Colson YL; Perkins DL
    Transplantation; 2007 Sep; 84(6):771-7. PubMed ID: 17893611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-23 antibody blockade of IL-23/IL-17 pathway attenuates airway obliteration in rat orthotopic tracheal transplantation.
    Cao H; Lan Q; Shi Q; Zhou X; Liu G; Liu J; Tang G; Qiu C; Qiu C; Xu J; Fan H; Liu Z
    Int Immunopharmacol; 2011 May; 11(5):569-75. PubMed ID: 21094688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence for a role of allograft accommodation in long-term tolerance.
    Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
    Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of IL-6 inhibition in prevention and treatment of antibody-mediated rejection in kidney allografts.
    Jordan SC; Ammerman N; Huang E; Vo A
    Am J Transplant; 2022 Dec; 22 Suppl 4():28-37. PubMed ID: 36453709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization.
    Kim I; Wu G; Chai NN; Klein AS; Jordan S
    Transplantation; 2014 Dec; 98(12):1262-70. PubMed ID: 25286051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic uses of anti-interleukin-6 receptor antibody.
    Kang S; Tanaka T; Kishimoto T
    Int Immunol; 2015 Jan; 27(1):21-9. PubMed ID: 25142313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
    Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 first plays pro- then anti-inflammatory role in early versus late acute renal allograft rejection.
    Wang X; Xu X; Huang H; Cai M; Qian Y; Li Z; Bai H; Han Y; Xiao L; Zhou W; Chen M; Shi B
    Ann Clin Lab Sci; 2013; 43(4):389-94. PubMed ID: 24247794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
    Neurath MF; Finotto S
    Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.